Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.
Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:
(12) Patent Application: | (11) CA 3155857 |
---|---|
(54) English Title: | PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS KRAS G12C AND KRAS G12D INHIBITORS IN THE TREATMENT OF CANCER |
(54) French Title: | DERIVES DE PYRIDOPYRIMIDINE UTILES EN TANT QU'INHIBITEURS DE KRAS G12C ET DE KRAS G12D DANS LE TRAITEMENT DU CANCER |
Status: | Compliant |
(51) International Patent Classification (IPC): |
|
---|---|
(72) Inventors : |
|
(73) Owners : |
|
(71) Applicants : |
|
(74) Agent: | SMART & BIGGAR LP |
(74) Associate agent: | |
(45) Issued: | |
(86) PCT Filing Date: | 2020-10-22 |
(87) Open to Public Inspection: | 2021-04-29 |
Availability of licence: | N/A |
(25) Language of filing: | English |
Patent Cooperation Treaty (PCT): | Yes |
---|---|
(86) PCT Filing Number: | PCT/US2020/056874 |
(87) International Publication Number: | WO2021/081212 |
(85) National Entry: | 2022-03-24 |
(30) Application Priority Data: | ||||||
---|---|---|---|---|---|---|
|
Provided herein are KRAS G12C and KRAS G12D inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
La présente invention concerne des inhibiteurs de KRAS G12C et de KRAS G12D, une composition de ceux-ci et des procédés d'utilisation de ceux-ci. Ces inhibiteurs sont utiles pour traiter un certain nombre de troubles, notamment le cancer du pancréas, le cancer colorectal et le cancer du poumon.
Note: Claims are shown in the official language in which they were submitted.
Sorry, the claims for patent document number 3155857 were not found.
Text is not available for all patent documents. The current dates of coverage are on the
Currency of Information
page
Note: Descriptions are shown in the official language in which they were submitted.
Sorry, the description for patent document number 3155857 was not found. Text is not available for all patent documents. The current dates of coverage are on the Currency of Information page
For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee and Payment History should be consulted.
Title | Date |
---|---|
Forecasted Issue Date | Unavailable |
(86) PCT Filing Date | 2020-10-22 |
(87) PCT Publication Date | 2021-04-29 |
(85) National Entry | 2022-03-24 |
There is no abandonment history.
Last Payment of $100.00 was received on 2023-09-20
Upcoming maintenance fee amounts
Description | Date | Amount |
---|---|---|
Next Payment if standard fee | 2024-10-22 | $125.00 |
Next Payment if small entity fee | 2024-10-22 | $50.00 |
Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following
Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO
Patent Fees
web page to see all current fee amounts.
Fee Type | Anniversary Year | Due Date | Amount Paid | Paid Date |
---|---|---|---|---|
Registration of a document - section 124 | 2022-03-24 | $100.00 | 2022-03-24 | |
Application Fee | 2022-03-24 | $407.18 | 2022-03-24 | |
Maintenance Fee - Application - New Act | 2 | 2022-10-24 | $100.00 | 2022-09-22 |
Maintenance Fee - Application - New Act | 3 | 2023-10-23 | $100.00 | 2023-09-20 |
Note: Records showing the ownership history in alphabetical order.
Current Owners on Record |
---|
AMGEN INC. |
Past Owners on Record |
---|
None |